In line with this, in vitro and in vivo experiments showed that Aβ trimers derived from postmortem human AD brains, induced conformational changes in tau that led to reduced expression of the kinesin-1 light chain and increased intra-axonal APP, suggesting disruption of axonal transport (Sherman et al., 2016). The gene discussed is APP; the disease is Alzheimer disease.